375 related articles for article (PubMed ID: 31419091)
1. Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape.
Glassberg MK
Am J Manag Care; 2019 Jul; 25(11 Suppl):S195-S203. PubMed ID: 31419091
[TBL] [Abstract][Full Text] [Related]
2. Improving outcomes and managing costs in idiopathic pulmonary fibrosis.
Morrow T
Am J Manag Care; 2019 Jul; 25(11 Suppl):S204-S209. PubMed ID: 31419090
[TBL] [Abstract][Full Text] [Related]
3. Management of Idiopathic Pulmonary Fibrosis.
Pleasants R; Tighe RM
Ann Pharmacother; 2019 Dec; 53(12):1238-1248. PubMed ID: 31280590
[No Abstract] [Full Text] [Related]
4. Current approaches to the management of idiopathic pulmonary fibrosis.
Raghu G; Richeldi L
Respir Med; 2017 Aug; 129():24-30. PubMed ID: 28732832
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Rogliani P; Calzetta L; Cavalli F; Matera MG; Cazzola M
Pulm Pharmacol Ther; 2016 Oct; 40():95-103. PubMed ID: 27481628
[TBL] [Abstract][Full Text] [Related]
6. Developments in the management of idiopathic pulmonary fibrosis.
Drug Ther Bull; 2015 Jul; 53(7):78-81. PubMed ID: 26159700
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic pulmonary fibrosis: A guide for nurse practitioners.
Vega-Olivo M; Criner GJ
Nurse Pract; 2018 May; 43(5):48-54. PubMed ID: 29465476
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic pulmonary fibrosis: the turning point is now!
Funke M; Geiser T
Swiss Med Wkly; 2015; 145():w14139. PubMed ID: 26024356
[TBL] [Abstract][Full Text] [Related]
9. The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis.
Aiello M; Bertorelli G; Bocchino M; Chetta A; Fiore-Donati A; Fois A; Marinari S; Oggionni T; Polla B; Rosi E; Stanziola A; Varone F; Sanduzzi A
Pulm Pharmacol Ther; 2017 Jun; 44():7-15. PubMed ID: 28257817
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological management of IPF.
Borie R; Justet A; Beltramo G; Manali ED; Pradère P; Spagnolo P; Crestani B
Respirology; 2016 May; 21(4):615-25. PubMed ID: 27072575
[TBL] [Abstract][Full Text] [Related]
11. Health economic evaluation in idiopathic pulmonary fibrosis in France.
Porte F; Cottin V; Catella L; Luciani L; Le Lay K; Bénard S
Curr Med Res Opin; 2018 Oct; 34(10):1731-1740. PubMed ID: 29368948
[TBL] [Abstract][Full Text] [Related]
12. A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK.
Rinciog C; Watkins M; Chang S; Maher TM; LeReun C; Esser D; Diamantopoulos A
Pharmacoeconomics; 2017 Apr; 35(4):479-491. PubMed ID: 28039616
[TBL] [Abstract][Full Text] [Related]
13. Treatment of idiopathic pulmonary fibrosis with Nintedanib: an update.
Wongkarnjana A; Yanagihara T; Kolb MR
Expert Rev Respir Med; 2019 Dec; 13(12):1139-1146. PubMed ID: 31564185
[No Abstract] [Full Text] [Related]
14. Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.
Jo HE; Troy LK; Keir G; Chambers DC; Holland A; Goh N; Wilsher M; de Boer S; Moodley Y; Grainge C; Whitford H; Chapman S; Reynolds PN; Glaspole I; Beatson D; Jones L; Hopkins P; Corte TJ
Respirology; 2017 Oct; 22(7):1436-1458. PubMed ID: 28845557
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study.
Marijic P; Schwarzkopf L; Schwettmann L; Ruhnke T; Trudzinski F; Kreuter M
Respir Res; 2021 Oct; 22(1):268. PubMed ID: 34666765
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations.
Jo HE; Randhawa S; Corte TJ; Moodley Y
Drugs Aging; 2016 May; 33(5):321-34. PubMed ID: 27083934
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic Pulmonary Fibrosis: A Case Discussion.
Felton MK; Bautista B; Morrow LE; Malesker M
Consult Pharm; 2017 Jul; 32(7):406-411. PubMed ID: 28701252
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential.
Raghu G
Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954769
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic pulmonary fibrosis.
Koudstaal T; Wijsenbeek MS
Presse Med; 2023 Sep; 52(3):104166. PubMed ID: 37156412
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management.
van Cleemput J; Sonaglioni A; Wuyts WA; Bengus M; Stauffer JL; Harari S
Adv Ther; 2019 Feb; 36(2):298-317. PubMed ID: 30554332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]